Annotation (Toggle Detail/Summary View) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene-Chemical Interaction Annotations
Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | decreases expression | ISO | RGD:3382 | 6480464 | Estradiol results in decreased expression of PPP3CA mRNA | CTD | PMID:20068009 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PPP3CA mRNA | CTD | PMID:21185374 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3382 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPP3CA mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11134 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPP3CA mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | ISO | RGD:3382 | 6480464 | 2,4-dinitrotoluene affects the expression of PPP3CA mRNA | CTD | PMID:21346803 | 2-deoxy-D-glucose | decreases response to substance | ISO | RGD:11134 | 6480464 | PPP3CA protein results in decreased susceptibility to Deoxyglucose | CTD | PMID:10679475 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:3382 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of PPP3CA mRNA | CTD | PMID:19162173 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:11134 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of PPP3CA mRNA | CTD | PMID:18648102 | 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of PPP3CA mRNA | CTD | PMID:12419474 | 5-fluorouracil | multiple interactions | EXP | | 6480464 | [Fluorouracil co-treated with irinotecan] results in increased expression of PPP3CA mRNA | CTD | PMID:16391804 | 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of PPP3CA protein | CTD | PMID:15585135 PMID:16803524 | 5-fluorouracil | multiple interactions | EXP | | 6480464 | PPP3CA protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] | CTD | PMID:18927307 | 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of PPP3CA protein | CTD | PMID:16803524 PMID:15585135 | acetazolamide | increases expression | ISO | RGD:11134 | 6480464 | Acetazolamide results in increased expression of PPP3CA mRNA | CTD | PMID:19274763 | aflatoxin B1 | decreases expression | ISO | RGD:11134 | 6480464 | Aflatoxin B1 results in decreased expression of PPP3CA mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of PPP3CA mRNA | CTD | PMID:16140955 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of PPP3CA mRNA | CTD | PMID:21934132 PMID:16140955 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of PPP3CA mRNA | CTD | PMID:16140955 PMID:21934132 | ammonium chloride | affects expression | ISO | RGD:3382 | 6480464 | Ammonium Chloride affects the expression of PPP3CA mRNA | CTD | PMID:16483693 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PPP3CA mRNA | CTD | PMID:20064835 PMID:20106945 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PPP3CA mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PPP3CA mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | decreases expression | ISO | RGD:11134 | 6480464 | Benzo(a)pyrene results in decreased expression of PPP3CA mRNA | CTD | PMID:21715664 PMID:20504355 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PPP3CA mRNA | CTD | PMID:20106945 PMID:20064835 | benzo[a]pyrene | decreases expression | ISO | RGD:11134 | 6480464 | Benzo(a)pyrene results in decreased expression of PPP3CA mRNA | CTD | PMID:20504355 PMID:21715664 | benzo[a]pyrene | multiple interactions | ISO | RGD:11134 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PPP3CA mRNA | CTD | PMID:21715664 | benzyl acetate | multiple interactions | EXP | | 6480464 | benzyl acetate results in increased cleavage of and results in increased activity of PPP3CA protein | CTD | PMID:22952646 | bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:11134 | 6480464 | Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of PPP3CA mRNA] | CTD | PMID:16377760 | bis(2-chloroethyl) sulfide | affects expression | ISO | RGD:3382 | 6480464 | Mustard Gas affects the expression of PPP3CA mRNA | CTD | PMID:15651846 | bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:11134 | 6480464 | Mustard Gas results in decreased expression of PPP3CA mRNA | CTD | PMID:16377760 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PPP3CA mRNA | CTD | PMID:12160620 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of PPP3CA mRNA | CTD | PMID:18560533 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of PPP3CA mRNA | CTD | PMID:16002434 | capsaicin | multiple interactions | ISO | RGD:3382 | 6480464 | PPP3CA protein affects the reaction [mustard oil inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]] | CTD | PMID:17590514 | carbamazepine | decreases expression | ISO | RGD:3382 | 6480464 | Carbamazepine results in decreased expression of PPP3CA mRNA; more ... | CTD | PMID:14642444 | chlorpyrifos | increases expression | ISO | RGD:11134 | 6480464 | Chlorpyrifos results in increased expression of PPP3CA mRNA | CTD | PMID:20350560 | cisplatin | multiple interactions | EXP | | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of PPP3CA mRNA | CTD | PMID:21858171 | clozapine | multiple interactions | ISO | RGD:3382 | 6480464 | [Clozapine binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein | CTD | PMID:16033416 | clozapine | increases expression | ISO | RGD:3382 | 6480464 | Clozapine results in increased expression of PPP3CA mRNA | CTD | PMID:12437575 | clozapine | decreases expression | ISO | RGD:3382 | 6480464 | Clozapine results in decreased expression of PPP3CA mRNA; more ... | CTD | PMID:16033416 | cocaine | affects expression | ISO | RGD:3382 | 6480464 | Cocaine affects the expression of PPP3CA mRNA | CTD | PMID:20187946 | cyclosporin A | decreases activity | ISO | RGD:11134 | 6480464 | Cyclosporine results in decreased activity of PPP3CA protein | CTD | PMID:19553475 | cyclosporin A | decreases expression | ISO | RGD:3382 | 6480464 | Cyclosporine results in decreased expression of PPP3CA protein | CTD | PMID:18344631 | cypermethrin | multiple interactions | EXP | | 6480464 | [cypermethrin results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin | CTD | PMID:10898953 | dimercaprol | multiple interactions | ISO | RGD:11134 | 6480464 | Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of PPP3CA mRNA] | CTD | PMID:16377760 | ethanol | multiple interactions | ISO | RGD:11134 | 6480464 | ALDH2 protein inhibits the reaction [Ethanol results in increased expression of PPP3CA protein] | CTD | PMID:19332462 | ethanol | decreases expression | ISO | RGD:3382 | 6480464 | Ethanol results in decreased expression of PPP3CA mRNA | CTD | PMID:20655511 | ethanol | increases expression | ISO | RGD:11134 | 6480464 | Ethanol results in increased expression of PPP3CA protein | CTD | PMID:19332462 | fenofibrate | multiple interactions | ISO | RGD:11134 | 6480464 | PPARA protein affects the reaction [Fenofibrate results in decreased expression of PPP3CA mRNA] | CTD | PMID:21318169 | fenofibrate | decreases expression | ISO | RGD:11134 | 6480464 | Fenofibrate results in decreased expression of PPP3CA mRNA | CTD | PMID:21318169 | furan | increases expression | ISO | RGD:3382 | 6480464 | furan results in increased expression of PPP3CA mRNA | CTD | PMID:20562052 | haloperidol | multiple interactions | ISO | RGD:3382 | 6480464 | [Haloperidol binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein | CTD | PMID:16033416 | haloperidol | decreases expression | ISO | RGD:3382 | 6480464 | Haloperidol results in decreased expression of PPP3CA mRNA; more ... | CTD | PMID:16033416 | methamphetamine | increases expression | ISO | RGD:3382 | 6480464 | Methamphetamine results in increased expression of PPP3CA protein | CTD | PMID:15644446 | methamphetamine | multiple interactions | ISO | RGD:3382 | 6480464 | SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of PPP3CA protein] | CTD | PMID:15644446 | methotrexate | affects response to substance | EXP | | 6480464 | PPP3CA protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | nitric oxide | decreases expression | ISO | RGD:11134 | 6480464 | Nitric Oxide deficiency results in decreased expression of PPP3CA mRNA | CTD | PMID:15878706 | paracetamol | affects expression | ISO | RGD:11134 | 6480464 | Acetaminophen affects the expression of PPP3CA mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PPP3CA mRNA | CTD | PMID:21420995 | perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:3382 | 6480464 | perfluorooctane sulfonic acid results in increased expression of PPP3CA mRNA | CTD | PMID:20136073 | perindopril | decreases expression | ISO | RGD:3382 | 6480464 | Perindopril results in decreased expression of PPP3CA protein | CTD | PMID:18344631 | phenobarbital | decreases expression | ISO | RGD:11134 | 6480464 | Phenobarbital results in decreased expression of PPP3CA mRNA | CTD | PMID:19363144 | pirinixic acid | decreases expression | ISO | RGD:11134 | 6480464 | pirinixic acid results in decreased expression of PPP3CA mRNA | CTD | PMID:21318169 | pirinixic acid | multiple interactions | ISO | RGD:11134 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of PPP3CA mRNA] | CTD | PMID:21318169 | piroxicam | multiple interactions | EXP | | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of PPP3CA mRNA | CTD | PMID:21858171 | propiconazole | decreases expression | ISO | RGD:11134 | 6480464 | propiconazole results in decreased expression of PPP3CA mRNA | CTD | PMID:19363144 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of PPP3CA mRNA | CTD | PMID:21632981 | risperidone | multiple interactions | ISO | RGD:3382 | 6480464 | [Risperidone binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein | CTD | PMID:16033416 | risperidone | decreases expression | ISO | RGD:3382 | 6480464 | Risperidone results in decreased expression of PPP3CA mRNA; more ... | CTD | PMID:16033416 | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:11134 | 6480464 | Buthionine Sulfoximine results in increased expression of PPP3CA mRNA | CTD | PMID:15878706 | staurosporine | decreases response to substance | ISO | RGD:11134 | 6480464 | PPP3CA protein results in decreased susceptibility to Staurosporine | CTD | PMID:10679475 | staurosporine | increases cleavage | EXP | | 6480464 | Staurosporine results in increased cleavage of PPP3CA protein | CTD | PMID:10898953 | tacrolimus hydrate | multiple interactions | EXP | | 6480464 | [Tacrolimus results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin | CTD | PMID:10898953 | tacrolimus hydrate | decreases activity | ISO | RGD:11134 | 6480464 | Tacrolimus results in decreased activity of PPP3CA protein | CTD | PMID:19553475 | tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of PPP3CA mRNA | CTD | PMID:12419474 | thapsigargin | multiple interactions | EXP | | 6480464 | [cypermethrin results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin; more ... | CTD | PMID:10898953 | thapsigargin | increases cleavage | EXP | | 6480464 | Thapsigargin results in increased cleavage of PPP3CA protein | CTD | PMID:10898953 | tocopherol | increases expression | ISO | RGD:11134 | 6480464 | Tocopherols results in increased expression of PPP3CA mRNA | CTD | PMID:17654050 | trichloroethene | multiple interactions | ISO | RGD:11134 | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of PPP3CA mRNA] | CTD | PMID:15363585 | trichloroethene | increases expression | ISO | RGD:3382 | 6480464 | Trichloroethylene results in increased expression of PPP3CA mRNA | CTD | PMID:19448997 | tunicamycin | increases expression | ISO | RGD:11134 | 6480464 | Tunicamycin results in increased expression of PPP3CA mRNA | CTD | PMID:17127020 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology Annotations
Molecular Pathway Annotations
Disease Annotations
|
|
|
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
|
|
|
|
|
|
|
|
Molecular Pathway Annotations
|
|
| External Database Links | |
| KEGG Pathway | Alzheimer's disease |
| Amphetamine addiction | |
| Amyotrophic lateral sclerosis (ALS) | |
| Apoptosis | |
| Axon guidance | |
| B cell receptor signaling pathway | |
| Calcium signaling pathway | |
| Dopaminergic synapse | |
| Glutamatergic synapse | |
| HTLV-I infection | |
| Long-term potentiation | |
| MAPK signaling pathway | |
| Natural killer cell mediated cytotoxicity | |
| Oocyte meiosis | |
| Osteoclast differentiation | |
| T cell receptor signaling pathway | |
| Tuberculosis | |
| VEGF signaling pathway | |
| Wnt signaling pathway | |
| Pathway Interaction Database | BCR signaling pathway (PID:200006) |
| C-MYB transcription factor network (PID:200153) | |
| Calcium signaling in the CD4+ TCR pathway (PID:200185) | |
| Downstream signaling in naïve CD8+ T cells (PID:200215) | |
| IL12 signaling mediated by STAT4 (PID:200229) | |
| IL12-mediated signaling events (PID:200045) | |
| Role of Calcineurin-dependent NFAT signaling in lymphocytes (PID:200090) | |
References - curated| 1. |
Bales JW, etal., J Neurotrauma. 2010 Jan;27(1):109-20. |
| 2. |
Gillis AM, etal., Cardiovasc Res. 2004 Dec 1;64(3):488-95. |
| 3. |
GOA_HUMAN data from the GO Consortium |
| 4. |
KEGG |
| 5. |
Koulmann N, etal., Am J Respir Crit Care Med. 2006 Jun 23;. |
| 6. |
Mansuy IM, etal., Cell 1998 Jan 9;92(1):39-49. |
| 7. |
Molkentin JD, etal., Cell. 1998 Apr 17;93(2):215-28. |
| 8. |
Pipeline to import KEGG annotations from KEGG into RGD Pathway Ontology |
| 9. |
Pipeline to import Pathway Interaction Database annotations from NCI into RGD |
| 10. |
RGD automated import pipeline for gene-chemical interactions |
| 11. |
Rodriguez A, etal., J Biol Chem. 2005 Mar 18;280(11):9980-4. Epub 2005 Jan 25. |
| 12. |
Shibasaki F and McKeon F, J Cell Biol. 1995 Nov;131(3):735-43. |
| 13. |
Vega RB, etal., Proc Natl Acad Sci U S A 2003 Jan 21;100(2):669-74. Epub 2003 Jan 6. |
| 14. |
Wilkins BJ and Molkentin JD, Biochem Biophys Res Commun. 2004 Oct 1;322(4):1178-91. |
| 15. |
Woolley SM, etal., J Thorac Cardiovasc Surg. 2004 Feb;127(2):376-84. |
| 16. |
Xifro X, etal., Neurobiol Dis. 2009 Dec;36(3):461-9. Epub 2009 Sep 4. |
References - uncurated| PubMed | 10089876 |
| 10195903 | |
| 10861295 | |
| 11005320 | |
| 11076863 | |
| 11114196 | |
| 11316738 | |
| 11439183 | |
| 11478781 | |
| 11513882 | |
| 11714752 | |
| 11842093 | |
| 12021260 | |
| 12063245 | |
| 12102656 | |
| 12135494 | |
| 12218175 | |
| 12477932 | |
| 12482669 | |
| 12510191 | |
| 12574411 | |
| 12577067 | |
| 12586544 | |
| 12809556 | |
| 14704270 | |
| 15454081 | |
| 15489334 | |
| 15489336 | |
| 15489953 | |
| 15671020 | |
| 15757646 | |
| 15955804 | |
| 16150694 | |
| 16189514 | |
| 16381901 | |
| 1659808 | |
| 17102134 | |
| 17320203 | |
| 17474147 | |
| 17478429 | |
| 18029348 | |
| 18296442 | |
| 18628988 | |
| 18660489 | |
| 18815128 | |
| 19034380 | |
| 19154138 | |
| 19285944 | |
| 19458075 | |
| 19492085 | |
| 19879877 | |
| 19913121 | |
| 20107831 | |
| 20379146 | |
| 20379614 | |
| 20413672 | |
| 20422345 | |
| 20501444 | |
| 20514436 | |
| 20590401 | |
| 20593291 | |
| 20605778 | |
| 20628086 | |
| 20647544 | |
| 20700529 | |
| 21047202 | |
| 21070662 | |
| 21139048 | |
| 21233773 | |
| 21420386 | |
| 2162844 | |
| 21647268 | |
| 21674474 | |
| 21785830 | |
| 21890473 | |
| 21900206 | |
| 21903422 | |
| 21906983 | |
| 21979947 | |
| 22100452 | |
| 22164265 | |
| 22270398 | |
| 22285318 | |
| 22360420 | |
| 22506312 | |
| 22688515 | |
| 22691791 | |
| 22715070 | |
| 22739212 | |
| 22763476 | |
| 22863883 | |
| 22939629 | |
| 2556704 | |
| 2848250 | |
| 6330098 | |
| 7528941 | |
| 7543369 | |
| 8392375 | |
| 8521476 | |
| 8524402 | |
| 8978785 | |
| 9109491 | |
| 9655484 | |
| 9765270 | |
| 9880537 |
RGD Disease Portals| PPP3CA has been annotated in the following RGD Disease Portals. |
|||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
Comparative Map Data| PPP3CA (Homo sapiens) |
|
|||||||||||||||||||||||||||||||||||
| Ppp3ca (Mus musculus) |
|
|||||||||||||||||||||||||||||||||||
| Ppp3ca (Rattus norvegicus) |
|
Position Markers| D4S1591 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| WI-18296 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-50332 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-19097 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| RH98934 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| RH25535 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| G42352 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| J05479 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| G59661 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| G62618 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| G62859 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| G66787 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-106093 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-106455 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-142728 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| STS-N27154 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-67255 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-67693 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| WI-20975 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| WI-18743 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC4-996 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| RH66646 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| WI-16419 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| SHGC-67753 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| EST26A4-T |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| PPP3CA |
|
QTLs in Region (Human Genome Assembly GRCh37)| The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
Nucleotide Sequences| Nucleotide RefSeqs | NM_000944 | (Get FASTA) | Search GEO for Microarray Profiles |
| NM_001130691 | (Get FASTA) | Search GEO for Microarray Profiles | |
| NM_001130692 | (Get FASTA) | Search GEO for Microarray Profiles | |
| GenBank Nucleotide | AB451338 | (Get FASTA) | Search GEO for Microarray Profiles |
| AB451487 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01063687 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01063688 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01063689 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AC092671 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AK290532 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AL353950 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AMYH01014427 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AP001816 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AP001870 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AP001939 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AW973358 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AY904364 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC025714 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC098424 | (Get FASTA) | Search GEO for Microarray Profiles | |
| CH471057 | (Get FASTA) | Search GEO for Microarray Profiles | |
| EU192652 | (Get FASTA) | Search GEO for Microarray Profiles | |
| EU192653 | (Get FASTA) | Search GEO for Microarray Profiles | |
| J05480 | (Get FASTA) | Search GEO for Microarray Profiles | |
| L14778 | (Get FASTA) | Search GEO for Microarray Profiles |
| RefSeq Acc Id: | NM_001130692 | ||||||||||||||||||||
| RefSeq Status: | VALIDATED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001124164 | ||||||||||||||||||||
| Peptide Label: | isoform 3 | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_001130691 | ||||||||||||||||||||
| RefSeq Status: | VALIDATED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001124163 | ||||||||||||||||||||
| Peptide Label: | isoform 2 | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_000944 | |||||||||||||||||||||||||
| RefSeq Status: | VALIDATED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_000935 | |||||||||||||||||||||||||
| Peptide Label: | isoform 1 | |||||||||||||||||||||||||
| Position: |
|
Protein Sequences| Protein RefSeqs | NP_000935 | (Get FASTA) |
| NP_001124163 | (Get FASTA) | |
| NP_001124164 | (Get FASTA) | |
| GenBank Protein | AAA02631 | (Get FASTA) |
| AAA35634 | (Get FASTA) | |
| AAH25714 | (Get FASTA) | |
| AAY17314 | (Get FASTA) | |
| ABW74484 | (Get FASTA) | |
| ABW74485 | (Get FASTA) | |
| BAF83221 | (Get FASTA) | |
| BAG70152 | (Get FASTA) | |
| BAG70301 | (Get FASTA) | |
| CAB89253 | (Get FASTA) | |
| CAL38363 | (Get FASTA) | |
| CAL38589 | (Get FASTA) | |
| EAX06123 | (Get FASTA) | |
| EAX06124 | (Get FASTA) | |
| EAX06125 | (Get FASTA) | |
| Q08209 | (Get FASTA) |
Promoters| RGD ID: | 6867042 | ||||||||||
| Promoter ID: | EPDNEW_H6686 | ||||||||||
| Type: | initiation region | ||||||||||
| Name: | PPP3CA_1 | ||||||||||
| Description: | protein phosphatase 3, catalytic subunit, alpha isozyme | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Position: |
|
| RGD ID: | 6802578 | ||||||||||
| Promoter ID: | HG_KWN:48813 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid, NB4 | ||||||||||
| Transcripts: | NM_001130691, NM_001130692, OTTHUMT00000258379, UC003HVS.1, UC003HVT.1, UC003HVV.1, UC003HVW.2, UC010ILK.1 | ||||||||||
| Position: |
|
| RGD ID: | 6858660 | ||||||||||
| Promoter ID: | EPDNEW_H2495 | ||||||||||
| Type: | multiple initiation site | ||||||||||
| Name: | MIA3_1 | ||||||||||
| Description: | melanoma inhibitory activity family, member 3 | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Position: |
|
External Database Links| Database | Acc Id | Source(s) |
| COSMIC | PPP3CA | COSMIC |
| Ensembl Genes | ENSG00000138814 | ENTREZGENE |
| Ensembl Protein | ENSP00000320580 | ENTREZGENE |
| ENSP00000378323 | ENTREZGENE | |
| Ensembl Transcript | ENST00000323055 | ENTREZGENE |
| ENST00000394854 | ENTREZGENE | |
| Entrez Gene | 5530 | ENTREZGENE |
| Germonline | ENSG00000138814 | |
| HGNC ID | 9314 | ENTREZGENE |
| HomoloGene Group ID | 55497 | ENTREZGENE |
| HPRD ID | 00234 | ENTREZGENE |
| InterPro | Metallo_PEstase_dom | UniProtKB/Swiss-Prot |
| Ser/Thr-sp_prot-phosphatase | UniProtKB/Swiss-Prot | |
| IPI | IPI00179415 | UniProtKB/Swiss-Prot |
| IPI00747748 | UniProtKB/Swiss-Prot | |
| IPI00877617 | UniProtKB/TrEMBL | |
| IPI00910825 | UniProtKB/Swiss-Prot | |
| IPI00966317 | UniProtKB/TrEMBL | |
| IPI00984119 | UniProtKB/TrEMBL | |
| IPI00984843 | UniProtKB/TrEMBL | |
| KEGG Report | hsa:5530 | ENTREZGENE, UniProtKB/Swiss-Prot |
| OMIM | 114105 | OMIM |
| Pfam | Metallophos | UniProtKB/Swiss-Prot |
| PharmGKB | PA33678 | PharmGKB |
| PRINTS | STPHPHTASE | UniProtKB/Swiss-Prot |
| PROSITE | SER_THR_PHOSPHATASE | UniProtKB/Swiss-Prot |
| SMART | PP2Ac | UniProtKB/Swiss-Prot |
| UniGene | Hs.435512 | ENTREZGENE |
| UniProt | A1A441_HUMAN | UniProtKB/TrEMBL |
| A8W6Z8_HUMAN | UniProtKB/TrEMBL | |
| E7ETC2_HUMAN | UniProtKB/TrEMBL | |
| E9PK68_HUMAN | UniProtKB/TrEMBL | |
| E9PPC8_HUMAN | UniProtKB/TrEMBL | |
| H0YAB4_HUMAN | UniProtKB/TrEMBL | |
| PP2BA_HUMAN | UniProtKB/Swiss-Prot |
Nomenclature History| Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
|---|---|---|---|---|---|---|---|
| 2011-07-27 | PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme | PPP3CA | protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform | Symbol and/or name change | 39860 | APPROVED |
| More on PPP3CA | |||
![]() |
Entrez Gene | ||
![]() |
Ensembl Gene | ||
|
|
||
![]() |
HGNC Report | ||
![]() |
NCBI Map Viewer | ||
![]() |
Vista | ||
![]() |
Vista + UCSC | ||
| RGD Object Information | |
| RGD ID: | 730900 |
| Created: | 2003-12-10 |
| Species: | Homo sapiens |
| Last Modified: | 2013-03-05 |
| Status: | ACTIVE |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.




